Cargando…

Invasive Pneumococcal Disease diminish during the onset of COVID-19 in Japan between 2019 and 2022

Invasive pneumococcal disease (IPD) is a severe infection caused by Streptococcus pneumoniae. This study explores the influence of COVID-19 on IPD occurrence in Japan by using the time trend analysis. We found that the IPD trend changed dramatically after the emergence of COVID-19; first, the number...

Descripción completa

Detalles Bibliográficos
Autores principales:	Khongyot, Thanawat, Moriyasu, Taeko
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9167682/ https://www.ncbi.nlm.nih.gov/pubmed/35671951 http://dx.doi.org/10.1016/j.ijid.2022.05.064

Ejemplares similares

2574. Serotype Distribution of Streptococcus pneumoniae and Pneumococcal Vaccine Coverage in Adults in Turkey between 2019 and 2022
por: Hasçelik, Gülşen, et al.
Publicado: (2023)

Levofloxacin Use in Patients with Suspected Tuberculosis in a Community Hospital, Thailand: A Pilot Study
por: Khongyot, Thanawat, et al.
Publicado: (2022)

Pneumococcal Immunization for Adults in 2022
por: O’Neill, John H.
Publicado: (2022)

Invasive Streptococcus oralis Expressing Serotype 3 Pneumococcal Capsule, Japan
por: Chang, Bin, et al.
Publicado: (2022)

Effectiveness of 23-Valent Pneumococcal Polysaccharide Vaccine against Invasive Pneumococcal Disease in Adults, Japan, 2013–2017
por: Shimbashi, Reiko, et al.
Publicado: (2020)

The COVID-19 pandemic increased the demand for pneumococcal vaccination in Japan
por: Komori, Akira, et al.
Publicado: (2021)

Effect of the COVID-19 pandemic and state of emergency declarations on the relative incidence of legionellosis and invasive pneumococcal disease in Japan
por: Ghaznavi, Cyrus, et al.
Publicado: (2023)

Decline in invasive pneumococcal disease during COVID-19 pandemic in Taiwan
por: Juan, Hui-Chun, et al.
Publicado: (2021)

1320. Pneumococcal Meningitis Before and During Covid – 19 Pandemic in Uruguay, South America (2017 – 2022).
por: Delfino, Marcos, et al.
Publicado: (2023)

Substantial Decline in Invasive Pneumococcal Disease During Coronavirus Disease 2019 Pandemic in Hong Kong
por: Teng, Jade L L, et al.
Publicado: (2021)

Impact of the progressive uptake of pneumococcal conjugate vaccines on the epidemiology and antimicrobial resistance of invasive pneumococcal disease in Gipuzkoa, northern Spain, 1998–2022
por: Manzanal, Ayla, et al.
Publicado: (2023)

A Systematic Review of Studies Published between 2016 and 2019 on the Effectiveness and Efficacy of Pneumococcal Vaccination on Pneumonia and Invasive Pneumococcal Disease in an Elderly Population
por: Berild, Jacob Dag, et al.
Publicado: (2020)

Changes in the Incidence of Invasive Pneumococcal Disease in Calgary, Canada, during the SARS-CoV-2 Pandemic 2020–2022
por: Ricketson, Leah J., et al.
Publicado: (2023)

The Impact of Pneumococcal Conjugate Vaccine (PCV) Coverage Heterogeneities on the Changing Epidemiology of Invasive Pneumococcal Disease in Switzerland, 2005–2019
por: Oyewole, Oluwaseun Rume-Abiola, et al.
Publicado: (2021)

1515. Nationwide trends of invasive pneumococcal disease in Spain for the period 2009-2019
por: de Miguel, Sara, et al.
Publicado: (2020)

Incorporation of the Anticancer Agent KRN5500 into Polymeric Micelles Diminishes the Pulmonary Toxicity
por: Mizumura, Yasuo, et al.
Publicado: (2002)

Serotype Distribution and Antimicrobial Resistance of Streptococcus pneumoniae Causing Invasive Pneumococcal Disease in Korea Between 2017 and 2019 After Introduction of the 13-Valent Pneumococcal Conjugate Vaccine
por: Kim, Gyu Ri, et al.
Publicado: (2023)

1718. Effectiveness of 13-valent pneumococcal conjugate vaccine for prevention of invasive pneumococcal disease among children in the United States between 2010 and 2019: an indirect cohort study
por: Andrejko, Kristin, et al.
Publicado: (2023)

Epidemiological and clinical features of invasive pneumococcal disease caused by serotype 12F in adults, Japan
por: Shimbashi, Reiko, et al.
Publicado: (2019)

Diminished Pneumococcal-Specific CD4(+) T-Cell Response is Associated With Increased Regulatory T Cells at Older Age
por: He, Samantha W. J., et al.
Publicado: (2021)

Association of Nonpharmaceutical Interventions During the COVID-19 Pandemic With Invasive Pneumococcal Disease, Pneumococcal Carriage, and Respiratory Viral Infections Among Children in France
por: Rybak, Alexis, et al.
Publicado: (2022)

Distribution and Variation of Serotypes and Pneumococcal Surface Protein A Clades of Streptococcus pneumoniae Strains Isolated From Adult Patients With Invasive Pneumococcal Disease in Japan
por: Chang, Bin, et al.
Publicado: (2021)

Declines in invasive pneumococcal disease (IPD) during the COVID-19 pandemic in Los Angeles county
por: Van Groningen, Karinne M, et al.
Publicado: (2022)

COVID-19 in Japan during 2020-2022: Characteristics, responses, and implications for the health care system
por: Karako, Kenji, et al.
Publicado: (2022)

Case fatality rate considering the lag time from the onset of COVID-19 infection to related death from 2020 to 2022 in Japan
por: Nojiri, Shuko, et al.
Publicado: (2023)

Dynamic models of pneumococcal carriage and the impact of the Heptavalent Pneumococcal Conjugate Vaccine on invasive pneumococcal disease
por: Melegaro, Alessia, et al.
Publicado: (2010)

Outbreak of invasive pneumococcal disease among shipyard workers, Turku, Finland, May to November 2019
por: Linkevicius, Marius, et al.
Publicado: (2019)

Streptococcus pneumoniae Serotype 12F-CC4846 and Invasive Pneumococcal Disease after Introduction of 13-Valent Pneumococcal Conjugate Vaccine, Japan, 2015–2017
por: Nakano, Satoshi, et al.
Publicado: (2020)

2596. Title: The Dynamics Of Invasive Pneumococcal Disease (IPD) due to Streptococcus pneumoniae and Impact Of Pneumococcal Conjugate Vaccines (PCVs) In Canada From 2000-2019
por: Ramos, Bernice N, et al.
Publicado: (2023)

Invasive Pneumococcal Disease and 7-Valent Pneumococcal Conjugate Vaccine, the Netherlands
por: van Deursen, Anna M.M., et al.
Publicado: (2012)

Seasonal respiratory virus circulation was diminished during the COVID‐19 pandemic
por: Heiskanen, Aliisa, et al.
Publicado: (2022)

Pneumococcal carriage among high-risk adults in a country with nonmandatory pneumococcal vaccination during the coronavirus disease 2019 pandemic
por: Ngamprasertchai, Thundon, et al.
Publicado: (2023)

Incidence of Invasive Pneumococcal Disease Before and During an Era of Use of Three Different Pneumococcal Conjugate Vaccines in Quebec
por: De Wals, Philippe, et al.
Publicado: (2017)

Notes from the Field: A Cluster of Multi-Strain Invasive Pneumococcal Disease Among Persons Experiencing Homelessness and Use of Pneumococcal Conjugate Vaccine — El Paso County, Colorado, 2022
por: Callaway, Jessica, et al.
Publicado: (2023)

Serotype Changes and Drug Resistance in Invasive Pneumococcal Diseases in Adults after Vaccinations in Children, Japan, 2010–2013
por: Ubukata, Kimiko, et al.
Publicado: (2015)

Invasive pneumococcal disease among adults in Japan, April 2013 to March 2015: disease characteristics and serotype distribution
por: Fukusumi, Munehisa, et al.
Publicado: (2017)

Change of Use in Community Services among Disabled Older Adults during COVID-19 in Japan
por: Ito, Tomoko, et al.
Publicado: (2021)

Promising Expectations for Pneumococcal Vaccination during COVID-19
por: Im, Hyobin, et al.
Publicado: (2021)

Invasive pneumococcal disease affected the fatal outcome in a COVID-19 patient
por: Kuronuma, Koji, et al.
Publicado: (2021)

Invasive Pneumococcal Disease in a Patient With COVID-19: A Case Report
por: Ayad, Sarah, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_akvrm47m3obtjh4km74074r3n7